Systemic treatment of advanced pancreatic cancer--step by step progress

Affiliations

Comment

Thomas Seufferlein. Gut. 2013 May.

. 2013 May;62(5):660-1.

doi: 10.1136/gutjnl-2012-303129. Epub 2012 Sep 5.

¹ Department of Internal Medicine I, Ulm University, Albert-Einstein-Allee 23, Ulm D-89081, Germany. thomas.seufferlein@uniklinik-ulm.de

No abstract available

Comment on

Gemcitabine plus erlotinib followed by capecitabine versus capecitabine plus erlotinib followed by gemcitabine in advanced pancreatic cancer: final results of a randomised phase 3 trial of the 'Arbeitsgemeinschaft Internistische Onkologie' (AIO-PK0104).
Heinemann V, Vehling-Kaiser U, Waldschmidt D, Kettner E, Märten A, Winkelmann C, Klein S, Kojouharoff G, Gauler TC, von Weikersthal LF, Clemens MR, Geissler M, Greten TF, Hegewisch-Becker S, Rubanov O, Baake G, Höhler T, Ko YD, Jung A, Neugebauer S, Boeck S. Heinemann V, et al. Gut. 2013 May;62(5):751-9. doi: 10.1136/gutjnl-2012-302759. Epub 2012 Jul 7. Gut. 2013. PMID: 22773551 Free PMC article. Clinical Trial.